Skip to Content
  • Review
  • Open Access

10 September 2020

47 Pages

State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy

,
,
,
,
,
,
,
,
…
1
Department of Cardiology, Royal Papworth Hospital, Cambridge CB2 0AY, UK
2
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland
3
School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SP, UK
4
Clinical Pharmacology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK

Abstract

Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy characterised by ventricular arrhythmia and an increased risk of sudden cardiac death (SCD). Numerous genetic determinants and phenotypic manifestations have been discovered in ACM, posing a significant clinical challenge. Further to this, wider evaluation of family members has revealed incomplete penetrance and variable expressivity in ACM, suggesting a complex genotype-phenotype relationship. This review details the genetic basis of ACM with specific genotype-phenotype associations, providing the reader with a nuanced perspective of this condition; whilst also proposing a future roadmap to delivering precision medicine-based management in ACM.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.